Synapse - Sara Kravetz

Sara Kravetz

Research Focus

Medicine; Research Project Manager

Recent additions – View all

Phase I dose escalation safety and feasibility study of autologous WT1-sensitized T cells for the treatment of patients with recurrent ovarian cancer
Journal Article

Kyi, C.; Doubrovina, E.; Zhou, Q.; Kravetz, S.; Iasonos, A.; Aghajanian, C.; Sabbatini, P.; Spriggs, D.; O'Reilly, R. J.; O'Cearbhaill, R. E.
Journal for ImmunoTherapy of Cancer (2021)

Fulltext@MSK | Save
A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
Journal Article

Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
Gynecologic Oncology (2020)

Fulltext@MSK | Save
A phase 2 study of TPIV200/ huFR-1 (a multi-epitope folate receptor alpha vaccine) in combination with durvalumab in patients with platinum resistant ovarian cancer
Meeting Abstract

Zamarin, D.; Yeku, O.; O'Cearbhaill, R. E.; Cadoo, K. A.; Gallagher, J.; Kravetz, S.; McDonnell, A.; Troso-Sandoval, T.; Sabbatini, P.; Lichtman, S.; more...
Clinical Cancer Research (2019)

Fulltext@MSK | Save

Co-authors at MSK

Types of Work

Publications

Journal of Clinical Oncology (3)
Cancers (1)
Cancer (1)
Clinical Cancer Research (1)
Gynecologic Oncology (1)
International Journal of Gynecological Cancer (1)
Journal for ImmunoTherapy of Cancer (1)